Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
about
Patient-level costs of major cardiovascular conditions: a review of the international literatureDerivation and validation of a risk standardization model for benchmarking hospital performance for health-related quality of life outcomes after acute myocardial infarction.Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study.Development and validation of a short version of the Seattle angina questionnaire.Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction.Extended-release ranolazine: critical evaluation of its use in stable angina.Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 surveyA protocol of histone modification-based mechanistic study of acupuncture in patients with stable angina pectoris.Association of smoking status with health-related outcomes after percutaneous coronary intervention.Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Changes in social support within the early recovery period and outcomes after acute myocardial infarction.Depressive symptoms in younger women and men with acute myocardial infarction: insights from the VIRGO studyCognitive impairment and outcomes in older adult survivors of acute myocardial infarction: findings from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry.Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction.Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey.Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT).Change in Angina Symptom Status After Acute Myocardial Infarction and Its Association With Readmission Risk: An Analysis of the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMFrequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trialPatient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study.Angina Frequency After Acute Myocardial Infarction In Patients Without Obstructive Coronary Artery Disease.Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus.Impact of angina frequency on health utility values of patients with chronic stable anginaNoncardiac chest pain after acute myocardial infarction: Frequency and association with health status outcomes.Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery DiseaseThe beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina.From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity.Clinical experience with ranolazine in a veteran population with chronic stable angina.Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.Preinfarct Health Status and the Use of Early Invasive Versus Ischemia-Guided Management in Non-ST-Elevation Acute Coronary Syndrome.Dyspnea Among Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Intervention: Prevalence and Predictors of Improvement.The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives.Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).A comparison of cardiac computerized tomography and exercise stress electrocardiogram test for the investigation of stable chest pain: the clinical results of the CAPP randomized prospective trial.Prediction of residual angina after percutaneous coronary intervention.Current Indications for Stenting: Symptoms or Survival CME.
P2860
Q28076912-2C13CBA3-78F7-4DDE-8640-74E25BBCA420Q33920774-4FE8E508-99BB-4314-AE44-8C2FE3E6AB5AQ33928977-64A39B58-5E05-456F-AACB-79B6F5E8B6B5Q34353509-524FACA0-B9A8-4AE0-8FAE-B8E57EAB3D6FQ34807134-39636F3C-C25D-4F25-BF56-FE56865F44D1Q35135687-A04971D9-483E-4128-8434-95105EE929E2Q35193935-39869732-987B-4E0D-9648-187870DAEF40Q35268223-2E28E233-5D85-4409-B1A0-5F5DA57E62B2Q35618271-7AA63CAE-E816-46B9-A1B6-9F51E6EEF4F9Q35619481-C5936CFC-C497-4EC5-8778-E156A6CD4E0DQ35873307-B9662395-8DE7-4E1B-A52A-67485FC49BDFQ36031069-17D90320-367F-46E1-91FF-61820A525F62Q36085691-AD657D1D-5952-45E5-ABAF-BD2F2DB352FFQ36136507-7C169F4E-BD9A-4608-B228-112191F6C542Q36258672-B3CE1148-90A5-48A7-8811-B349E08D905FQ36263380-8D95B80E-D3FB-43BF-8FDD-BD3F12559CC7Q36436790-7FC2BB46-FA03-40D5-9691-D4C4E66F83DEQ36897358-ECD22175-8EC0-4992-B5C3-89191313B653Q37074525-DA6CA230-82FE-4100-AA70-12D8AC9C709DQ37076132-4769F87E-D7B1-4F9C-B47B-8B30EDBB583AQ37521237-3BA6C125-3BB0-4C34-8249-10A6A50A0888Q37607046-263333D3-9DC8-44B6-BF48-9EB466B4C6BCQ37660304-870C5619-CCC6-4B8E-B7F1-68668A756397Q37661212-4D639726-DBAB-421A-9DBC-88AB42AE9BBCQ37686974-7269E070-C6F3-4C6D-AE08-BFABE12A2863Q37716587-F3178CAD-87B9-4E76-877A-5886ED410814Q40222578-AAAAE273-FB4F-4037-BDDD-B2ACA940DCFFQ41145172-6B540514-806B-4760-B184-D1FF17FF716FQ41630374-C13B0568-D4EB-48DF-8271-DA59DA053187Q42678879-2883B419-C62E-4C27-AB50-5A6CAAD27341Q45330316-B56DD2B3-4842-425B-B15C-0DDE46E2DC63Q45965347-9643C1DC-E2F9-42DE-B32A-894E8F9EAF84Q47554123-B7056B94-1C3E-4732-8BE0-AA7C36B50503Q47565458-16D58EF8-D877-486C-9F57-A2F5EC72BAA1Q47579827-30AD583A-B342-430C-9339-F8A2C16BA11CQ50113889-6EEF42B4-502A-420F-835B-65A0104C0614Q51744045-D07C83E5-AEDC-4200-80FC-AA95B5751200Q51766004-AF68A9AB-94CB-4F5E-ABEB-DBDD8C2B1F9DQ55020637-502469AB-165F-4D89-A30A-454AD37CCF01Q55315249-F066CDBF-9D5B-4D62-866A-CFE08C9E3DFB
P2860
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@ast
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@en
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@nl
type
label
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@ast
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@en
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@nl
prefLabel
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@ast
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@en
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@nl
P2093
P1476
Economic impact of angina afte ...... from the MERLIN-TIMI 36 trial.
@en
P2093
David A Morrow
David J Cohen
Elizabeth M Mahoney
Paul S Chan
Suzanne V Arnold
P304
P356
10.1161/CIRCOUTCOMES.108.829523
P577
2009-06-02T00:00:00Z